Continuity of Cardiac Care for South Nassau Patients

Patient Bill Regan with, from left: Robin Varghese, MD; Pilar Stevens-Haynes, MD; and Jason
Freeman, MD—members of the coordinated team that treated him on Long Island and in Manhattan.

Even before an official partnership was finalized in December 2018, specialists from the Mount Sinai Health System were collaborating with physicians at South Nassau Communities Hospital to provide advanced and coordinated care to Long Island patients. For 67-year-old Bill Regan, a retired financial services executive from Massapequa, this new relationship proved to be life-saving.

It was in March 2018 that Mr. Regan decided to try a new primary care physician—this time, at South Nassau Primary Care at Bellmore. During his first visit to Carolyne McHyman, DO, Mr. Regan provided the details of his medical history, which included a carotid endarterectomy, a surgical procedure to clear blockages in the carotid artery in the neck, and prescriptions for high blood pressure and high cholesterol. The former long-time smoker told Dr. McHyman that he was “generally in good health,” but when he also mentioned some daytime fatigue and left leg discomfort when he walked long distances, she ordered several diagnostic tests.

They included a chest CT scan, as part of The Mount Sinai Hospital’s Early Detection Lung Cancer Screening program; an ultrasound of the abdominal aorta to check circulation and to rule out an aortic aneurysm, an abnormal bulge in the aorta; a consultation to rule out a sleep disorder; and a recommendation to see his cardiologist, Pilar Stevens-Haynes, MD, for an evaluation.

The CT scan of the lungs, while negative for lung cancer, showed calcification in his aorta. The ultrasound of the abdominal aorta also showed narrowing of the left iliac artery in his pelvis, while a magnetic resonance angiography, which provides detailed images of blood vessels in the body, revealed a 90 percent blockage of that artery. “Honestly, I didn’t worry about my health, but these test results blindsided me,” recalls Mr. Regan.

Meanwhile, Dr. Stevens-Haynes recommended a cardiac catheterization to check for any blockages of his coronary arteries. “Bill didn’t have previous symptoms of chest pain, but coronary artery calcification can be associated with major adverse cardiovascular events, and we needed to get to the bottom of it,” says Dr. Stevens-Haynes.

When Jason Freeman, MD, Director of Interventional Cardiology at South Nassau Communities Hospital, performed the cardiac catheterization on April 24, he discovered that Mr. Regan’s left main and circumflex coronary arteries that supply blood to his heart were significantly blocked and could not be treated with stents, expandable tubes used to open clogged arteries. Now, Mr. Regan would need open-heart surgery—a diagnosis that was made immediately by Robin Varghese, MD, Associate Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, who was at South Nassau that day.

South Nassau’s Center for Cardiovascular Health has long been known for its outstanding care. It is a recipient of Healthgrades’ 2019 Coronary Intervention Excellence Award and five stars for its performance in coronary interventional procedures, placing it among the top 10 percent in the nation; however, it does not perform cardiac surgery.

“When I met with Dr. Varghese, the heart surgeon, I was very anxious, but I came out feeling this is going to be okay,” Mr. Regan says. “He walked me through what the procedure entailed. He had a diagram of the heart and the arteries, and he was positive, calming, and reassuring. He made me feel like ‘we got this and this is what we do every day.’”

Long Island patient Bill Regan was able to receive postoperative care, including cardiac rehabilitation, close to home in South Nassau.

On April 30, Dr. Varghese and his team at The Mount Sinai Hospital performed the three-hour surgery to restore blood flow to Mr. Regan’s heart. “After surgery, we took Bill to our Cardiac Surgery Intensive Care Unit,” says Dr. Varghese, who is also Director of Cardiovascular Critical Care for the Mount Sinai Health System. “He was sitting up in the chair in no time and looking great. He surprised us all.” Within four days, Mr. Regan was released from the hospital and was back home on the South Shore under the supervision of South Nassau’s Homecare program, attending church two days later in Massapequa.

“My entire experience was coordinated and supported by the most wonderful people from South Nassau and Mount Sinai,” says Mr. Regan. “I feel blessed, thankful, and overwhelmed with gratitude to everyone, and I mean everyone, involved in my treatment and recovery at South Nassau and Mount Sinai.”

After he was released from South Nassau’s Homecare program, vascular surgeon Xenophon Xenophontos, MD, performed a successful angioplasty of the left iliac artery. Mr. Regan also participated in South Nassau’s Cardiac Rehabilitation program at South Nassau’s Sports Medicine and Rehabilitation Therapy (SMART) Center in Oceanside, which he completed three months ago. Mr. Regan says he plans to return to the SMART Center this month for additional exercise programs.

Having access to advanced specialty care at The Mount Sinai Hospital while being able to stay close to home for pre- and postoperative care offers many benefits for patients. “Continuity of care is a key component of quality of care, especially when treating patients with multiple conditions,” says Adhi Sharma, MD, Executive Vice President for Clinical and Professional Affairs and Chief Medical Officer at South Nassau. “The care was not only life-saving for Bill, but a seamless journey and patient experience.”

 

New Program Achieves Early Benchmarks For Improving Patient Care Post-Discharge

The Transitions of Care Center team includes, from left: Amanda Anderson, MSN, MPA, RN; Claudia Colgan; and Eunice Reynoso, BSN, RN, Clinical Nurse Manager.

When a patient is admitted to a hospital within the Mount Sinai Health System, planning for discharge begins almost immediately to ensure a smooth transition to the next level of care, whether it is at home or at a skilled nursing facility. Studies show that effective discharges lead to improved patient health, reduced readmissions, and decreased health care costs.

Toward that end, the Mount Sinai Health System has established the Transitions of Care Center (TOCC), a centralized telephone-based discharge program staffed by Mount Sinai registered nurses who are specially trained in hospital discharge protocols and are led by a clinical nurse manager.

The TOCC has been tasked with improving patient satisfaction, ensuring patients have access to post-hospital care and are following discharge instructions, and preventing avoidable readmissions. Staff work from a dedicated office on East 16th Street near Union Square in Manhattan, where 11 registered nurses call Mount Sinai patients 24 to 72 hours after they leave the hospital—reviewing and addressing each patient’s unique discharge plan of care.

The Center initially was launched in December 2016 as a pilot program aimed exclusively at patients deemed at high risk for rehospitalization. The program quickly expanded and is now servicing patients regardless of readmission risk or diagnosis who are discharged home from The Mount Sinai Hospital, Mount Sinai Queens, Mount Sinai West, and Mount Sinai St. Luke’s. In March, the TOCC will add discharged patients from Mount Sinai Brooklyn, with a goal to expand to Mount Sinai Beth Israel in the coming months.

Since the program’s start, nurses have made more than 40,000 phone calls, spoken to nearly 19,000 patients, and provided close to 11,000 interventions to assist patients with post-discharge care needs. “The results have been positive,” says Claudia Colgan, Vice President, Care Coordination, Mount Sinai Health System, and Vice President, Operations, The Mount Sinai Hospital. “In the 12 months leading up to August 2018, patients who were contacted by the TOCC had a 16 percent lower-than-expected readmission rate.”

The Transitions of Care Center nursing staff includes Verisa Robinson BSN, RN, center, and from left: Alla Aminova, BSN, RN; Maki Lahori, BSN, RN; Kristina Davanzo, BSN, RN; Amanda Mendez- Paranavitana, BSN, RN; Connie Fong, BSN, RN; and April Schott-Auerbach MSN, RN, CNL.

While speaking to patients, nurses assess their health status and determine if they are adhering to their discharge care plan. They ensure that patients have filled their prescriptions and are taking their medications properly, that they have the medical equipment they need, and that they are able to attend follow-up appointments. As needed, they perform nursing triage for active symptoms, referring patients  to in- and out-patient providers. They work closely with interdisciplinary care management teams at the hospital where the patient was treated and collaborate with ambulatory teams, home health agencies, and community-based service organizations.

According to TOCC data from January 2017 through November 2018, nurses had 6,290 patient interventions that involved providing educational resources and reinforcing overall discharge instructions, and 1,013 interventions that resolved medication needs. They also helped escalate the management of active symptoms for 825 patients.

“No matter how well the discharge team explains next steps of care, patients often do not fully understand or remember what to do,” says Ms. Colgan. “This is pervasive across the entire patient population, regardless of education or language proficiency or socioeconomic status. At Mount Sinai, we understand that they may be overwhelmed with new directives.”

Mount Sinai is one of the few facilities in the country with a dedicated team of on-staff nurses whose full-time job is to call patients. “Our success lies with our registered nursing team,” says Amanda Anderson, MSN, MPA, RN, Associate Director of Care Transitions for the Mount Sinai Health System. “The TOCC nurses are highly trained by Health System service-line leaders. They understand the Mount Sinai culture of putting patients first, and they collaborate with other hospital staff on the patient’s behalf when necessary.”

“It’s great when we are able to triage and provide a service to someone who really needs it,” says TOCC Senior Nurse April Schott-Auerbach, MSN, RN, CNL. “One of my patients was experiencing increasing shortness of breath and it was clear he needed assistance but was unable to get to an urgent care facility or go back to the emergency room. I was able to triage and collaborate with the Health System Community Paramedicine team, which provided the patient with the more immediate assessment he needed.”

According to Ms. Schott-Auerbach, patients are happy knowing that someone is following up with them. One of her patients told her, “I never had such amazing service from other hospitals. It really makes me feel like Mount Sinai cares about me.”

A team picture: The Transitions of Care team.

 

Dubin Gala Honors Champions of Breast Cancer Care and Awareness

 

At the benefit gala, from left: Elisa Port, MD, FACS; Eva Andersson-Dubin, MD; and Amy Tiersten, MD.

A leading physician-scientist and three “passionate champions” of breast cancer awareness were honored by the Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System at its eighth annual benefit. The celebratory event, held on Monday, December 10, at the Ziegfeld Ballroom in Manhattan, attracted 520 guests and raised $2.6 million to support the Center’s breast health and treatment programs.

The three “champions” were Melissa Spohler, Meredith Shepherd, and their mother, Priscilla Alexander—all diagnosed with breast cancer in their 50s. “This is a family of women who have strength. They have integrity, they are kind, they give to others,” says Eva Andersson-Dubin, MD, founder of the Dubin Breast Center and Mount Sinai Health System Trustee, who presented awards to the honorees with Elisa Port, MD, FACS, the Center’s Director. “These are women we should all look up to as role models to see how they deal with breast cancer.”

Also honored at the gala was a “spectacular clinical investigator,” Amy Tiersten, MD, Clinical Director of Breast Medical Oncology, The Mount Sinai Hospital, and Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai. “I have really poured a lot of lifeblood and energy into building a research program and clinical practice and collaborating with all the wonderful other physicians at the Dubin Breast Center,” says Dr. Tiersten, who specializes in metastatic breast cancer. “Through Dr. Tiersten’s research, we can provide our patients with the next generation of treatments—treatments that provide hope,” Dr. Port says.

The event included music by accomplished performers, including LaChanze, Ariana DeBose, and Storm Lever from Summer: The Donna Summer Musical on Broadway. And Ms. Alexander, 81, gave a moving speech about the Dubin Breast Center, saying that it did not yet exist when she was treated with cancer at age 53, but it now provides “great comfort” to her daughters and other patients.

From left: honorees Melissa Spohler, Priscilla Alexander, and Meredith Shepherd

“My daughters are part of a sisterhood at the Center,” Ms. Alexander says. “They have the good fortune of being watched over by the best professionals in their specialties, trained at the cutting edge of testing, diagnosis, treatment, emotional support, and ongoing research.” As a patient at another New York City hospital 28 years ago, Ms. Alexander had a double mastectomy and took an early test for a BRCA (breast cancer susceptibility) gene mutation. The test was negative. But because her mother and four of her six female cousins had all been treated for breast cancer, Ms. Alexander urged her four daughters to be vigilant. Ms. Shepherd says, “In hearing my family’s history, everyone’s first question is ‘Are you a BRCA family?’ I always say, ‘No, we’re a something family, it just hasn’t been found yet.’”

Ms. Spohler, 56, had at least one breast screening test every six months starting at age 40. In March 2016, a radiologist saw ambiguous “bright spots” on an MRI, and six months later an ultrasound identified breast cancer. “I was lucky because it was discovered when it was small,” Ms. Spohler says. “I had a double mastectomy because I didn’t want to live with the fear of it coming back.” Ms. Shepherd, 52, was diagnosed with breast cancer in August 2018. Her radiologist saw a small mass in her right breast, and a biopsy found that it was a benign growth called a papilloma. Ms. Shepherd says she went “right away” to Dr. Port, who had also treated her sister. As part of a preoperative check before removing the growth, Dr. Port ordered an MRI. That test discovered breast cancer unrelated to the papilloma, and Ms. Shepherd also had a double mastectomy.

All of the honorees say the key to early detection is awareness. “I would say to any woman that if you have breasts, you are potentially at risk,” Ms. Spohler says. “You have to monitor yourself. You have to know your own history and know your family’s history, because that is what might save you.”

Mount Sinai and Sema4 Launch Groundbreaking Asthma Study With Global Pharmaceutical Company

Andrew Kasarskis, PhD, left, and Linda Rogers, MD, are part of the asthma study team.

Asthma, a chronic disease of the airways of the lungs, is a growing public health problem that now affects 350 million people and results in about 400,000 deaths worldwide each year. Its diagnosis and treatment remain challenging, however, and debilitating symptoms, such as coughing and shortness of breath, are a major cause behind rising health care costs, missed school for children, and loss of productivity and early disability in adults.

Recently, the Mount Sinai Health System and Sema4—a patient-centered predictive health company and a venture of Mount Sinai—joined with Sanofi, one of the world’s largest pharmaceutical companies, to follow 1,200 Mount Sinai patients to gain unprecedented insights into the biological mechanisms and environmental factors implicated in this condition.

The five-year study—the first of its kind—will collect traditional clinical data, such as electronic medical records and clinical samples, including blood samples and nasal brushings, from  patients during their doctor appointments. The data will be analyzed for genomic and transcriptomic information and combined with other data collected using the patient’s mobile phone—environmental data, like air quality and pollen counts, data from the patient’s asthma inhaler, and data from home monitoring of activity and sleep. One of the unique elements of this study is that the research will be incorporated into actual clinical practice, and real-world data using remote devices will be integrated with molecular data.

“Despite advances in recent years, we still see many patients struggling with asthma, so there is a tremendous need for innovation to reduce the burden of this disease,” says Linda Rogers, MD, Associate Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine) and Clinical Director of the Adult Asthma Program at the Mount Sinai – National Jewish Health Respiratory Institute. Dr. Rogers is the clinical principal investigator of the study, which is a collaboration among the Respiratory Institute, the Icahn Institute of Genomics and Multiscale Biology, Sema4, and Sanofi.

The Respiratory Institute is uniquely positioned to undertake this research. In addition to the large number of asthma patients that the program treats, the Mount Sinai and Sema4 study team have unparalleled capabilities in specimen analysis, data science, and multiscale biological modeling, allowing researchers to gather large amounts of data more rapidly than using more traditional research methods.

Clinical research teams will deploy advanced analytics on this information to better understand how the disease functions, including what triggers asthma attacks and which patient segments are most likely to respond to certain therapies. “This collection of large amounts of multiple types of data is needed to fully understand asthma—a condition researchers now believe is far more complex than was previously understood—and how best to treat patients,” says Tom Neyarapally, Sema4’s Chief Commercial Officer.

Significantly, gathering and analyzing these kinds of data from patients will demonstrate at the molecular level how their bodies are responding to asthma, says Andrew Kasarskis, PhD, Executive Vice President and Chief Data Officer for the Mount Sinai Health System and a co-principal investigator of the study. For example, analysis of a blood sample will show changes in the cellular activity, such as which proteins are being produced, and a nasal swab may reveal important clues about one’s immune response and what is happening in the lungs.

“We will define asthma subtypes clinically, then understand the molecular basis of disease in each subtype in order to discover new therapies and better manage asthma in all our patients,” says Dr. Kasarskis.

Ultimately, adds Erik Lium, PhD, Executive Vice President of Mount Sinai Innovation Partners, “this collaboration may lead to the identification of novel drug targets and the development of groundbreaking therapies to benefit all patients with asthma.”

 

A New Waiting Room that Supports Men’s Health

The idea that men often take better care of their cars than their own health led to the recent opening of a sports-themed waiting room at the Milton and Carroll Petrie Department of Urology’s midtown office at 625 Madison Avenue. The special space was designed to serve as a refuge for male patients waiting for a doctor’s appointment or looking for
educational resources on prostate health or men’s health.

Amid the mounted football jerseys belonging to former Super Bowl winners and other framed sports memorabilia featured in the room, male patients can find information on medical services, holistic treatments, or emotional support when dealing with a critical prostate diagnosis.

Ash Tewari, MBBS, MCh, left, and Tom Milana Jr. celebrated the opening of the waiting room with a ribbon-cutting.

The new space was donated by Man Cave Health, Inc., a nonprofit led by philanthropist and Mount Sinai Health System patient Tom Milana Jr., a prostate cancer survivor who recognized the need to raise awareness about the disease and men’s health as he was recovering from his 2016 diagnosis.

At the official ribbon-cutting ceremony in January, Mr. Milana said, “This is a place where men can get educated, screened, and treated for prostate cancer in a welcoming environment. Our goal is to get more men to go to the doctor for their annual screening, which will lead to fewer prostate cancer deaths in this country.”

Mr. Milana’s physician at Mount Sinai, Ash Tewari, MBBS, MCh, the Kyung Hyun Kim, MD Chair in Urology, said, “Men avoid going to the doctor. I think this room makes a difference. They can come here and relax.”

The inspirational message, he added, is about winning at sports and winning the fight against cancer.

Good Morning America Features Young Mount Sinai Kidney Patient’s ‘Medical Miracle’

Doctors at Mount Sinai Kravis Children’s Hospital have performed a ‘medical miracle’ on eight-year-old Lexi. Born without a bladder and with both kidneys blocked, she first underwent surgery at age six so doctors could create an artificial bladder. In January she received a kidney transplant, with her father as the donor.

Watch the video on Good Morning America